ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

1,3-ジヒドロキシ-2-(ヒドロキシメチル)アントラキノン

Lucidin

HCID 10163
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
478-08-0
標準SMILES
O=C1c2ccccc2C(=O)c2c1cc(O)c(CO)c2O
InChIKey
AMIDUPFSOUCLQB-UHFFFAOYSA-N
分子式
C15H10O5
平均分子量
270.24 g/mol
単同位体質量
270.05282342

概要

Lucidin is a dihydroxyanthraquinone.

名称と識別子

優先名称
Lucidin
IUPAC
1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione
現地名
1,3-ジヒドロキシ-2-(ヒドロキシメチル)アントラキノン
英語名
LUCIDIN
分子式
C15H10O5
分子量
270.24

名称と別名

Lucidin478-08-0Henine1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dioneLucidin (quinone)1,3-Dihydroxy-2-(hydroxymethyl)anthraquinoneDTXSID101972781,3-Dihydroxy-2-hydroxymethylanthraquinolineNSC-30546Anthraquinone, 1,3-dihydroxy-2-(hydroxymethyl)-60Q5564O9D9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)-
名称をさらに表示
1,3-ジヒドロキシ-2-(ヒドロキシメチル)アントラキノンルシジンルシジン【キノン】1,3-ジヒドロキシ-2-ヒドロキシメチルアントラセン-9,10-ジオン1,3-ジヒドロキシ-2-(ヒドロキシメチル)-9,10-ジヒドロアントラセン-9,10-ジオンCS-1096Lucidin-RMLucidin, BRLucidin【quinone】NSC 30546|||HenineLucidin (Standard)
Madder rootRefChem:1542191,3-Dihydroxy-2-hydroxymethyl-9,10-anthraquinoneDTXCID20119769NSC 30546CCRIS 1642Lucidin (NSC 30546)1,3-dihydroxy-2-(hydroxymethyl)-9,10-dihydroanthracene-9,10-dione

データベース識別子

CAS
478-08-0
PubChem CID
10163
DTXSID
DTXSID10197278
ChEBI
CHEBI:6554
UNII
60Q5564O9D
EC Number
683-115-4
Nikkaji
J12.586E

物性

構造計算による物性

XLogP
2.4
極性表面積
94.8 Ų
水素結合供与体数
3
水素結合受容体数
5
回転可能結合数
1
重原子数
20
形式電荷
0
複雑度
420

実験および物理化学的性質

Chemical ClassesBiological Agents -> Plant Toxins
Melting Point330 °C
Dissociation ConstantspKa= 8.11 (20 °C, water)

物理化学的性質

融点
330 ℃ · >330℃
沸点
333.35 °C · 333.35°C (rough estimate)
比重(密度)
1.592 · 1.592±0.06 g/cm3 (20 ºC 760 Torr)
屈折率
1.6 · 1.6000 (estimate)
貯蔵温度
Sealed in dry,Room Temperature
溶解性
Soluble in DMSO
外見
Solid
酸解離定数(Pka)
6.83 · 6.83±0.20(Predicted)
色
Light yellow to yellow
主な用途
食品および飲料
InChI
1S/C15H10O5/c16-6-10-11(17)5-9-12(15(10)20)14(19)8-4-2-1-3-7(8)13(9)18/h1-5,16-17,20H,6H2
InChIKey
AMIDUPFSOUCLQB-UHFFFAOYSA-N
SMILES
OCc1c(c2c(cc1O)C(=O)c3c(cccc3)C2=O)O

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazards SummaryAnthraquinone is a toxic component of plants that can cause diarrhea, GI bleeding, kidney injury, dyspnea, and seizures; [Olson, p. 376]
Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Natural Pollution Sources · 1 件

Lucidin has been identified in plants from Rubia (R. tinctorum, R. iberica), Coprosma (C. lucida, C. rotundifolia, C. acerosa), Morinda (M. citrifolia, M. umbellata), Galium (G. fagetorum, G. mollugo, G. dasypodum), Hymenodictyon (H. excelsum) and Commitheca (C. liebrechtsiana) species.

Human Toxicity Excerpts · 3 件

/HUMAN EXPOSURE STUDIES/ The largest outbreak reported to date occurred in the Gulran district of Herat Province in northwest Afghanistan, close to the border of the USSR. ...The outbreak, was estimated to have affected a population of approximately 35,000 in 98 villages. Examination of 7,200 inhabitants of the affected villages showed evidence of disease in 22.6%, which was more serious in 15%. Thus, it was estimated that approximately 8,000 subjects suffered from the disease including 5,000 who were seriously affected. All age groups were affected, but 46% of subjects were below 14 years of age. However, no sign of disease was found in children below 2 years of age. A detailed report concerning the pathological material obtained from 14 liver biopsies and 8 autopsies was made... /although/ the time interval between the onset of symptoms and the biopsy/autopsy was not indicated. Pathological findings were characteristic, ranging from acute disease with characteristic veno-occlusion to non-portal cirrhosis, which was observed in 5 of the above 22 cases. The outbreak was ascribed to massive contamination of wheat, the staple food crop, following 2 years of drought, with the seeds of Heliotropium popovii H. Riedl subsp. gillianum H. Riedl, which had been growing profusely among the wheat crop. The seeds contained pyrrolizidine alkaloids at concentrations reported by 2 laboratories to be 7.2 and 13.2-14.9 g/kg, identified mainly as the N-oxide of heliotrine (74%)..., and one or two other compounds similar in character to lasiocarpine. Samples of wheat from several villages contained an average of 40 seeds/kg, i.e., 0.03% by weight. It was estimated that an adult consumed at least 700 g flour/day, containing approximately 2 mg alkaloid (based on a mean of the seed analyses). /Pyrrolizidine alkaloids/

/HUMAN EXPOSURE STUDIES/ The two main sources of pyrrolizidine alkaloid poisoning reported in human beings are the consumption of cereal grain contaminated by weeds containing the alkaloids and the use of alkaloid-containing herbs for medicinal and dietary purposes. ...Three of the largest outbreaks of the disease have been reported from South Asia, two from the same site in central India and one from North-West Afghanistan. The first Indian outbreak... occurred in a group of 5 tribal villages in central India in 1972-73. ...Out of a total population of 2,060 in these villages, 71 households with 366 members were investigated. Among these, 39 cases had developed and 19 had died before commencement of the investigations. The incidence rate was 1.1% and the case fatality rate was 50%. All cases occurred among 20 households. In many households, several members were affected. In one household, 4 out of 5 cases died. ...The etiological factor of this outbreak was not established, though dietary contamination with pyrrolizidine alkaloids was considered. A second outbreak occurred at the same site in 1975... . A total population of 486 was affected, 67 cases were reported, of whom 28 (46%) had died. There was a strong family history... . In a later survey, 108 patients were studied and the mortality rate was estimated to be 63%. This time the etiological factor was identified as the plant Crotalaria nana Burm, which had been growing in the fields of millet (Panicum miliare), their staple food crop. The seeds of this plant became mixed with the cereal grain during harvesting. The toxic seeds contained pyrrolizidine alkaloids that were identified as a macrocyclic ester closely similar to monocrotaline. The total alkaloid content was estimated to be 5.3 g/kg of seed, expressed as monocrotaline. The levels of contamination of the millet with seeds were reported to be 0-3.4 g/kg in the unaffected and 0-19 g/kg in the affected households... . /Pyrrolizidine alkaloids/

/SIGNS AND SYMPTOMS/ After intake of madder root, occasional cases of red coloration of the urine, saliva, perspiration, and milk have been observed.

Carcinogen Classification · 5 件

Madder root (Rubia tinctorum)

Group 3: Not classifiable as to its carcinogenicity to humans

Volume 82: (2002) Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene

2002

2002

Non-Human Toxicity Excerpts · 5 件

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Groups of 15-20 male and female ACI rats, weighing 150-200 g, were fed a standard diet containing 0, 1 or 10% madder root (Rubia tinctorum) for 780 days. This root contained lucidin (0.34%) but also large amounts of alizarin (0.67%; 1,2-dihydroxyanthraquinone) and the primeverosides of both compounds. All surviving animals were killed and necropsied at 780 days. In the groups receiving 10% madder root diet, 2/16 males and 3/17 females developed hepatocellular adenomas, whereas none were observed in the controls or the 1% madder root group of either sex. In addition, renal tubule-cell adenomas were observed in 1/16 males and 2/16 females in the 10% madder root group and a renal tubule-cell carcinoma in 1/14 males in the 1% madder root group. No renal tumors were seen in the control groups.

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Madder root, Rubia tinctorum L., is a traditional herbal medicine used against kidney stones. Recently /it was/ reported that lucidin, a hydroxyanthraquinone derivative present in this plant, is mutagenic in bacteria and mammalian cells. ...The formation of DNA adducts in tissue culture and mice /were also demonstrated/ after treatment with this compound. To elucidate the possible carcinogenicity of madder root, three groups of male and female ACI rats received either a normal diet or a diet supplemented with 1 or 10% drug for a total period of 780 days. Weight gain and morbidity were not different among the three groups. Non-neoplastic lesions related to the treatment were evident in the liver and kidneys of both sexes. Moreover, dose-dependent increases in benign and malignant tumor formation were observed in the liver and kidneys of treated animals. 32P-post-labelling analysis showed an increase in the overall level of DNA adducts observed in the liver, kidney and colon of rats treated with 10% madder root in the diet for 2 weeks. HPLC analysis of 32P-labelled DNA adducts revealed a peak co-migrating with an adduct obtained after in vitro treatment of deoxyguanosine-3'-phosphate with lucidin.

/GENOTOXICITY/ The genotoxic activity of lucidin (1,3-dihydroxy-2-hydroxymethyl-9,10-anthraquinone), ... was tested in a battery of short-term tests. The compound was mutagenic in five Salmonella typhimurium strains without metabolic activation, and the mutagenicity was increased after addition of rat liver S9 mix. In V79 cells, lucidin was mutagenic at the hypoxanthine-guanine phosphoribosyl transferase gene locus and active at inducing DNA single-strand breaks and DNA-protein cross-links as assayed by the alkaline elution method. Lucidin also induced DNA repair synthesis in primary rat hepatocytes and transformed C3H/M2-mouse fibroblasts in culture.

/GENOTOXICITY/ Mutagenicity of anthraquinone aglycones from Rubia tinctorum L. (Rubiaceae) was examined using the somatic mutation and recombination test in Drosophila melanogaster. Larvae heterozygous for recessive wing trichome mutations, multiple wing hairs (mwh), and flare (flr3) were exposed to test compounds and wings of emerged mwh/flr3 females were inspected for the presence of phenotypically mutant mosaic spots. No significant increase in the frequency of mutant spots was observed after the treatment of Drosophila larvae with pure lucidin.

Evidence for Carcinogenicity · 1 件

Evaluation: There is limited evidence in experimental animals for the carcinogenicity of madder root (Rubia tinctorum). Overall evaluation: Madder root (Rubia tinctorum) is not classifiable as to its carcinogenicity to humans (Group 3). /Madder root (Rubia tinctorum)/

Antidote and Emergency Treatment · 2 件

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam (Valium) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poison A and B/

安全データ

wgk
WGK 3
Hazard Classifications
Acute Tox. 4 OralCarc. 2
ストレージクラス
11 - Combustible Solids
有毒物質データの
478-08-0(Hazardous Substances Data)

化学と産業

薬理情報

Mechanism of Action · 1 件

A mutagenic anthraquinone, lucidin, occurring in Rubiaceae plants, reacted with nucleic bases under physiological conditions to form adducts. ... The isolated purine base adducts were identified as condensed reactants at the benzylic position of 1 with a nitrogen atom of a purine base.

用途と製造

Uses · 2 件

A hydroxyanthraquinone component of Rubia tinctorum (madder root) and several other plants; Used in traditional herbal medicines; [IARC]

The /IARC/ Working Group was not aware of any commercial use of purified lucidin.

Methods of ManufacturingLucidin has been synthesized from nordamnacanthal.
General Manufacturing Information · 1 件

Lucidin has been identified in plants from Rubia (R. tinctorum, R. iberica), Coprosma (C. lucida, C. rotundifolia, C. acerosa), Morinda (M. citrifolia, M. umbellata), Galium (G. fagetorum, G. mollugo, G. dasypodum), Hymenodictyon (H. excelsum) and Commitheca (C. liebrechtsiana) species.

サプライヤー92 社

南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
銘瑞集團有限公司17318633522 · [email protected]
成都乐美天医药科技有限公司17308096051 17308096051 · [email protected]
上海纯优生物科技有限公司15921393123 18302135232 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
成都彼样生物科技有限公司18108052721 · [email protected]
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd+86-13119157289 · [email protected]
成都市久鼎化学技术有限公司18584079237 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
武汉众志诚生物技术有限公司13628624121 13628604890 · [email protected]
成都普睿法药物研发有限公司82633860 18982077548 · [email protected]
Aladdin Scientific[email protected]
上海颖心实验室设备有限公司021-59178156 17002132182 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
上海诗丹德标准技术服务有限公司021-021-57127007-6622-6622 17621252073 · [email protected]
United Life Science020-82099279 18988968278 · [email protected]
成都普思生物科技股份有限公司028-85370565-229 18080489829 · [email protected]
InvivoChem中国13549236410 · [email protected]
成都普菲德生物技术有限公司028-82610909 13388174823 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
武汉市皇臻生物化工有限公司13795480948 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
ChemeGen 中国18818260767 · [email protected]
Apeloa Pharmaceutical Co., Ltd.+86-0571-87635730 +8615858229168 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
成都麦德生科技有限公司028-82253651 18140204969 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
上海卓因生物科技有限公司021-61317773 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
ALB Technology Limited702-983-3769 · [email protected]
武汉天植生物技术有限公司18607101326 15172504745 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
斯派螺(武汉)药物研发有限公司[email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
Alfa Chemistry+1-5166625404 · [email protected]
风咏生物(AbMole)021-10000000 13000000000 · [email protected]
四川普西奥标物科技有限公司13540909846 13882008651 · [email protected]
EMMX Biotechnology LLC888-539-0666 · [email protected]
广州市齐云生物技术有限公司020-61288194 61288195 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
深圳市创鑫生物科技有限公司13417589054 · [email protected]
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
上海澄绍生物科技有限公司021-61847300 13341622919 · [email protected]
Cckinase, Inc.+1 (732)236-3202 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

For more Non-Human Toxicity Excerpts (Complete) data for LUCIDIN (9 total), please visit the HSDB record page.